C. Guenther

Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.

J. Thaden, N. Shire, V. Fowler, 2016, The Journal of infectious diseases.

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa

Wei Zhao, J. Suzich, Cuihua Gao, 2014, Science Translational Medicine.

Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage

Jonathan M. Brunger, F. Guilak, C. Gersbach, 2014, Proceedings of the National Academy of Sciences.

Synthetic virology: engineering viruses for gene delivery.

J. Suh, Julia Zhao, B. Kuypers, 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Reducing off target viral delivery in ovarian cancer gene therapy using a protease-activated AAV2 vector platform.

J. Suh, M. J. Brun, M. Ho, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Protease-Activatable Adeno-Associated Virus Vector for Gene Delivery to Damaged Heart Tissue.

E. Sevick-Muraca, D. Sousa, M. Agbandje-McKenna, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Adeno-Associated Virus (AAV) Vectors: Rational Design Strategies for Capsid Engineering.

J. Suh, C. Guenther, Esther J. Lee, 2018, Current opinion in biomedical engineering.

Using molecular imaging to assess the delivery and infection of protease activated virus in animal model of myocardial infarction

Eva M. Sevick-Muraca, Banghe Zhu, Sunkuk Kwon, 2017, BiOS.